Evidence map›Paper›PMID 40585088›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Attention-based deep learning for analysis of pathology images and gene expression data in lung squamous premalignant lesions.

Lingyi Xu, Yohana Kefella, Yichi Zhang, Regan D Conrad, Kelley E Anderson, Kostyantyn Krysan, Gang Liu, Erin Kane, Adam Pennycuick, Sam M Janes and 6 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Lingyi XuFaculty of Computing & Data Sciences, Boston University, MA, USA.
Yohana KefellaDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Yichi ZhangDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Regan D ConradDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Kelley E AndersonDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Kostyantyn KrysanDepartment of Medicine, David Geffen School of Medicine at UCLA, CA, USA.
Gang LiuDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Erin KaneDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Adam PennycuickLungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Mary E ReidRoswell Park Comprehensive Cancer Center, Buffalo, NY, 14203, USA.
Eric J BurksDepartment of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Ehab BillatosDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Sarah A MazzilliDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Vijaya B KolachalamaFaculty of Computing & Data Sciences, Boston University, MA, USA.ORCID 0000-0002-5312-8644
Jennifer E BeaneDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0002-6699-2132

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary PremalignancyU2CCA233238 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DUBINETT, STEVEN M., SPIRA, AVRUM E · 2018 to 2021
$7.0M
Digital Cognitive Assessment of Preclinical Alzheimer's Disease and Related DementiasR01AG083735 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Vijaya B. Kolachalama · 2024 to 2026
$2.4M
Mechanisms of drug-coated balloon therapyR01HL159620 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOLACHALAMA, VIJAYA B. · 2021 to 2024
$2.1M
Digital Neurodegenerative Pathology After Repetitive Head ImpactsR01NS142076 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Jonathan D Cherry, Vijaya B. Kolachalama · 2025 to 2026
$1.7M
Cognitive heterogeneity in those with high Alzheimer's Disease RiskR01AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Vijaya B. Kolachalama · 2025 to 2026
$1.6M
PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learningR21CA253498 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BEANE, JENNIFER ELLEN, KOLACHALAMA, VIJAYA B. · 2020 to 2020
$424k
NCATS NIH HHS UL1 TR001430NCI NIH HHS R21 CA253498NCI NIH HHS U2C CA233238NHLBI NIH HHS R01 HL159620NIA NIH HHS R01 AG062109NIA NIH HHS R01 AG083735NINDS NIH HHS R01 NS142076
6 · The paper itself

Abstract

Molecular and cellular alterations to the normal pseudostratified columnar bronchial epithelium results in the development of bronchial premalignant lesions representing a spectrum of histology from normal to hyperplasia, metaplasia, dysplasia (mild, moderate, and severe), carcinoma in situ and invasive carcinoma. Several studies have identified molecular alterations associated with lesion histology and progression. The broad and continuous spectrum of histologic and molecular changes makes reproducible stratification of lesions across multiple studies challenging. Here we propose a transformer-based framework that flexibly utilizes transcriptomic and histologic patterns to distinguish lesions with bronchial dysplasia or worse from normal, hyperplasia, and metaplasia. We leveraged H&E whole slide images (WSIs) of endobronchial biopsies and bulk gene expression data (GE) from previously published studies and on-going lung precancer atlas efforts obtained from patients as high-risk for lung cancer. Models trained using both WSIs and GE compared to a single data modality had higher performance. On an external testing dataset of WSIs, the area under the ROC curve (AUROC) of the model trained on WSIs plus GE was 0.761±0.015 compared to 0.690±0.027 for model trained on WSIs. On external testing datasets of GE, the AUROC of the model trained on WSIs plus GE was 0.890±0.023 versus 0.816±0.032 for a model trained on GE. Based on these results, we leveraged data across 4 studies to train a flexible fusion model that allows one or both data modalities to be used in training. The model achieved an AUROC of 0.809±0.036 on external testing WSIs data and 0.903±0.022 on external testing GE data. Despite model training on a binary label, model probabilities are associated with histologic grade and the model identifies gene expression alterations associated with bronchial dysplasia across multiple studies. This framework maps bronchial premalignant lesions that contain at least one data modality into a spectrum of disease. In the future, a framework trained on multiple data modalities may be useful in predicting premalignant disease severity, progression, and interception agent efficacy.

Indexed as

deep learningdigital pathologydysplasiapre-cancer

Identifiers

PMID40585088
PMCPMC12204423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.